Autopsy report · NCT03046901

Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients

“0 subjects enrolled”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Ochsner Health System

Sponsor type

University, hospital or other

Conditions

Primary Sclerosing Cholangitis; Post- Orthotopic Liver Transplantation

Interventions

Vancomycin

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Proactive Counselling Towards Follow-ups in Newborn Hearing Screening
  “no subjects enrolled” (88% match in meaning)
• A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer
  “0 participants enrolled” (84% match in meaning)
• Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
  “No subjects were enrolled.” (80% match in meaning)
• Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence
  “Few subject enrolled” (77% match in meaning)
• Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea
  “No eligible subjects were identified.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.